Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk
EX-TIMING
Another Look to Exercise Prescription: Exercise Timing and the Circadian Clock in Individuals With Type 2 Diabetes and Those at Risk
1 other identifier
interventional
34
1 country
1
Brief Summary
Many investigations have been done to determine the exercise that can elicit the greatest benefits on glycemic control and metabolic health, with findings suggesting that incorporation of higher intensity and longer duration of exercise prescribed may eliminate much of the "non-response" observed following exercise training. Even with the incorporation of higher intensity exercise into interventions aimed at improving glycemic control in individuals with type 2 diabetes mellitus (T2DM), the investigators and others continue to have mixed results, with not all individuals with T2DM obtaining benefits in insulin sensitivity and glycemic control to a given exercise training program. Many of the metabolic processes involved in glucose homeostasis, such as insulin production and sensitivity, undergo daily circadian rhythms, controlled by cellular clock machinery located both centrally and peripherally (i.e. skeletal muscle). However, in adults with T2DM, these diurnal rhythms are impaired, with reduced insulin sensitivity in the morning, which is thought to contribute to the fasting hyperglycemia (i.e., "dawn phenomenon") observed in these individuals. Exercise may be a non-photic cue that can amplify or alter these metabolic rhythms. It has been suggested that skeletal muscle metabolic inflexibility in metabolic disorders such as overweight/obesity and T2DM is associated with reduced mitochondrial fatty acid oxidative capacity. It has been demonstrated that exercise can increase mitochondrial oxidative capacity by remodeling mitochondrial morphology and dynamics. It is unknown if potential differences in metabolic flexibility can be found in response to exercise at different times of the day. Most of the experimental evidence originates from animal models with only 3 studies performed in humans with T2DM, which displayed conflicting results. To overcome the shortcomings in the literature, the main objective of this research project is to assess the effects of performing exercise at different times of the day on glycemic control and related outcomes on the inter-individual response variability in glycemic control and related metabolic health parameters in two distinct populations: 1) individuals with T2DM on the most common mono-hyperglycemic drug therapy (i.e., metformin); and 2) age-matched sedentary overweight/obese individuals, where glycemic control is known to deteriorate, hence increasing the risk of developing insulin resistance and T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Jan 2024
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedNovember 18, 2023
November 1, 2023
6 months
July 26, 2023
November 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in 24-hour area under cover (AUC) glucose from baseline to 1, 2, and 3 months
Assess differences in 24-hour area under cover (AUC) glucose at different exercise times (i.e. morning, afternoon and evening) separately for individuals with T2DM and age-matched overweight/obese older adults.
3 months
Secondary Outcomes (12)
Changes in body mass index (BMI) from baseline to 1, 2, and 3 months
3 months
Changes in bone mineral density from baseline to 1, 2, and 3 months
3 months
Changes in fat and lean body mass from baseline to 1, 2, and 3 months
3 months
Changes in resting metabolic rate (RMR) from baseline to 1, 2, and 3 months
3 months
Changes in respiratory quotient from baseline to 1, 2, and 3 months
3 months
- +7 more secondary outcomes
Study Arms (3)
Morning HIIT 30-min following breakfast between 9:00 to 10:00 am.
EXPERIMENTALThe exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.
Afternoon HIIT 30-min following lunch between 2:00 to 3:00 pm.
EXPERIMENTALThe exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.
Evening HIIT 30-min following dinner between 7:00 to 8:00 pm.
EXPERIMENTALThe exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.
Interventions
1 minute of exercise at 90% of their PPO, followed by a 1-minute rest at 40-60% of their peak power output using a cycle ergometer.
Eligibility Criteria
You may qualify if:
- previous diagnosis of T2DM
- currently taking metformin (Group 1 only);
- Adults aged 55 to 75 years
- Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)
You may not qualify if:
- Use of exogenous insulin and taking any other antihyperglycemic medication beyond metformin
- having major micro- or macro-vascular complications from T2DM
- History of cardiovascular incidents
- People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
- inability to provide informed consent
- BMI ≥25 without diagnosis of T2DM
- Adults aged 55 to 75 years
- Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)
- History of cardiovascular incidents
- People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
- inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculdade de Motricidade Humana
Cruz Quebrada, Oeiras, 1409-002, Portugal
Related Publications (1)
Magalhaes JP, Oliveira EC, Hetherington-Rauth M, Jesus F, Rodrigues MC, Raposo JF, Ribeiro RT, Caetano C, Sardinha LB. The Ex-Timing trial: evaluating morning, afternoon, and evening exercise on the circadian clock in individuals with type 2 diabetes and overweight/obesity-a randomized crossover study protocol. Trials. 2024 Aug 6;25(1):526. doi: 10.1186/s13063-024-08335-y.
PMID: 39107793DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
João B Magalhães, PhD
Faculdade de Motricidade Humana - Universidade de Lisboa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2023
First Posted
November 18, 2023
Study Start
January 1, 2024
Primary Completion
July 1, 2024
Study Completion
December 1, 2024
Last Updated
November 18, 2023
Record last verified: 2023-11